000 01464 a2200421 4500
005 20250517235827.0
264 0 _c20181217
008 201812s 0 0 eng d
022 _a1177-8881
024 7 _a10.2147/DDDT.S171475
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDogterom, Peter
245 0 0 _aAsenapine pharmacokinetics and tolerability in a pediatric population.
_h[electronic resource]
260 _bDrug design, development and therapy
_c2018
300 _a2677-2693 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAntipsychotic Agents
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aDibenzocycloheptenes
650 0 4 _aFemale
650 0 4 _aHeterocyclic Compounds, 4 or More Rings
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMental Disorders
_xdrug therapy
700 1 _aRiesenberg, Robert
700 1 _ade Greef, Rik
700 1 _aDennie, Justin
700 1 _aJohnson, Martin
700 1 _aPilla Reddy, Venkatesh
700 1 _aMiltenburg, André Mm
700 1 _aFindling, Robert L
700 1 _aJakate, Abhijeet
700 1 _aCarrothers, Timothy J
700 1 _aTroyer, Matthew D
773 0 _tDrug design, development and therapy
_gvol. 12
_gp. 2677-2693
856 4 0 _uhttps://doi.org/10.2147/DDDT.S171475
_zAvailable from publisher's website
999 _c28834379
_d28834379